clenbuterol has been researched along with Muscular Dystrophy, Duchenne in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clenbuterol treatment did not increase the normalized force or power output of diaphragm strips from either mdx or control mice." | 1.31 | Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment. ( Faulkner, JA; Hinkle, RT; Lynch, GS, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lynch, GS | 1 |
| Hinkle, RT | 1 |
| Faulkner, JA | 1 |
1 other study available for clenbuterol and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Diaphragm; Disease Models, Animal; Mice; Mice, Inbre | 2001 |